Rosane Charlab

20.6k total citations
46 papers, 2.0k citations indexed

About

Rosane Charlab is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Rosane Charlab has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Public Health, Environmental and Occupational Health and 9 papers in Oncology. Recurrent topics in Rosane Charlab's work include Research on Leishmaniasis Studies (12 papers), Insect Resistance and Genetics (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Rosane Charlab is often cited by papers focused on Research on Leishmaniasis Studies (12 papers), Insect Resistance and Genetics (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Rosane Charlab collaborates with scholars based in United States and Brazil. Rosane Charlab's co-authors include José M. C. Ribeiro, Jesús G. Valenzuela, Edgar Rowton, Thomas N. Mather, Richard Pazdur, Michael Y. Galperin, Van My Pham, Mark Garfield, Sarah E. Dorff and Kirsten B. Goldberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Rosane Charlab

44 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosane Charlab United States	22	634	619	473	419	327	46	2.0k
Helen P. Price United Kingdom	21	738 1.2×	793 1.3×	430 0.9×	59 0.1×	230 0.7×	60	2.2k
Deepti Pradhan United States	19	988 1.6×	109 0.2×	320 0.7×	152 0.4×	301 0.9×	26	1.7k
Nicholas J. Dickens United Kingdom	20	1.4k 2.3×	862 1.4×	249 0.5×	117 0.3×	197 0.6×	33	2.5k
Feng Han China	22	496 0.8×	226 0.4×	377 0.8×	46 0.1×	457 1.4×	46	1.5k
Marcello A. Barcinski Brazil	28	1.2k 1.9×	767 1.2×	1.0k 2.1×	34 0.1×	253 0.8×	67	2.9k
Sirintra Nakjang United Kingdom	22	945 1.5×	131 0.2×	108 0.2×	168 0.4×	302 0.9×	45	1.6k
Shuhong Luo China	29	853 1.3×	414 0.7×	410 0.9×	25 0.1×	247 0.8×	91	2.2k
Gilles Gadéa France	25	1.5k 2.3×	531 0.9×	239 0.5×	101 0.2×	29 0.1×	46	2.8k
F. Nina Papavasiliou United States	41	2.5k 4.0×	396 0.6×	2.2k 4.6×	143 0.3×	107 0.3×	78	4.9k
Tracey M. Baldwin Australia	23	487 0.8×	783 1.3×	639 1.4×	27 0.1×	210 0.6×	36	1.8k

Countries citing papers authored by Rosane Charlab

Since Specialization

Citations

This map shows the geographic impact of Rosane Charlab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosane Charlab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosane Charlab more than expected).

Fields of papers citing papers by Rosane Charlab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosane Charlab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosane Charlab. The network helps show where Rosane Charlab may publish in the future.

Co-authorship network of co-authors of Rosane Charlab

This figure shows the co-authorship network connecting the top 25 collaborators of Rosane Charlab. A scholar is included among the top collaborators of Rosane Charlab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosane Charlab. Rosane Charlab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chow, Edwin C.Y., Alexei Ionan, Shwu‐Luan Lee, et al.. (2024). FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation. Clinical Cancer Research. 30(19). 4266–4271. 2 indexed citations

Agrawal, Sundeep, William F. Pierce, Melanie Royce, et al.. (2024). FDA Approval Summary: Capecitabine Labeling Update under Project Renewal. Clinical Cancer Research. 30(24). 5508–5514.

Woods, Ashley, Kelly J. Norsworthy, Moran Choe, et al.. (2024). FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation. Clinical Cancer Research. 31(1). 12–17. 1 indexed citations

Bradford, Diana, Pallavi S. Mishra‐Kalyani, Yuan Li Shen, et al.. (2023). FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum. Clinical Cancer Research. 30(1). 23–28. 16 indexed citations

Larkins, Erin, Pallavi S. Mishra‐Kalyani, Stephanie Aungst, et al.. (2023). FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical Cancer Research. 29(17). 3262–3266. 33 indexed citations

Woods, Ashley, Kelly J. Norsworthy, Jonathon Vallejo, et al.. (2023). FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation. Clinical Cancer Research. 30(7). 1226–1231. 16 indexed citations

Gandhy, Shruti U., Sandra J. Casak, Sirisha L. Mushti, et al.. (2023). FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements. Clinical Cancer Research. 29(20). 4027–4031. 11 indexed citations

Zamboni, William C., Rosane Charlab, Gilbert J. Burckart, & Clinton F. Stewart. (2023). Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer Agents. The Journal of Clinical Pharmacology. 63(S2). S85–S102. 10 indexed citations

Marcus, Leigh, M. Naomi Horiba, Martha Donoghue, et al.. (2022). FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement. Clinical Cancer Research. 29(5). 838–842. 33 indexed citations

10.

Kumar, Vaibhav, Leslie Doros, Sirisha L. Mushti, et al.. (2022). FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor. Clinical Cancer Research. 29(11). 2020–2024. 6 indexed citations

11.

Norsworthy, Kelly J., Lola Luo, Vicky Hsu, et al.. (2019). FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation. Clinical Cancer Research. 25(11). 3205–3209. 102 indexed citations

12.

Schuck, Robert N., et al.. (2017). Leveraging Genomic Factors to Improve Benefit–Risk. Clinical and Translational Science. 10(2). 78–83. 3 indexed citations

13.

Florea, Liliana, Valentina Di Francesco, Jason Miller, et al.. (2005). Gene and alternative splicing annotation with AIR. Genome Research. 15(1). 54–66. 58 indexed citations

14.

Ribeiro, José M. C., Rosane Charlab, Van My Pham, Mark Garfield, & Jesús G. Valenzuela. (2004). An insight into the salivary transcriptome and proteome of the adult female mosquito Culex pipiens quinquefasciatus. Insect Biochemistry and Molecular Biology. 34(6). 543–563. 127 indexed citations

15.

Charlab, Rosane, Euzenir Nunes Sarno, Delphi Chatterjee, & María Cristina Vidal Pessolani. (2001). Effect of uniqueMycobacterium lepraephenolic glycolipid-I (PGL-I) on tumour necrosis factor production by human mononuclear cells. Leprosy Review. 72(1). 63–9. 10 indexed citations

16.

Ribeiro, José M. C., Rosane Charlab, Edgar Rowton, & Eddie W. Cupp. (2000). <I>Simulium vittatum</I> (Diptera: Simuliidae) and <I>Lutzomyia longipalpis</I> (Diptera: Psychodidae) Salivary Gland Hyaluronidase Activity. Journal of Medical Entomology. 37(5). 743–747. 38 indexed citations

17.

Barral, Aldina, Eiji Honda, J.‐M. Costa, et al.. (2000). Human immune response to sand fly salivary gland antigens: a useful epidemiological marker?. American Journal of Tropical Medicine and Hygiene. 62(6). 740–745. 127 indexed citations

18.

Ribeiro, José M. C., Edgar Rowton, & Rosane Charlab. (2000). The salivary 5′-nucleotidase/phosphodiesterase of the hematophagus sand lutzomyia fly, Lutzomyia longipalpis. Insect Biochemistry and Molecular Biology. 30(4). 279–285. 17 indexed citations

19.

Charlab, Rosane, et al.. (1995). Leishmania amazonensis: Sensitivity of Different Promastigote Morphotypes to Salivary Gland Homogenates of the Sand Fly Lutzomyia longipalpis. Experimental Parasitology. 80(2). 167–175. 15 indexed citations

20.

Charlab, Rosane, Christine Blaineau, Deborah Schechtman, & Marcello A. Barcinski. (1990). Granulocyte‐Macrophage Colony‐Stimulating Factor is a Growth‐Factor for Promastigotes of Leishmania mexicana amazonensis. The Journal of Protozoology. 37(5). 352–357. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact